Sign In
Buy CARM
$0.0001
+0 (+0%)
At Close: Jun 03, 2026
Critical Review: Carisma Therapeutics (NASDAQ:CARM) vs. Protalex (OTCMKTS:PRTX)
01:30am, Tuesday, 14'th Apr 2026
Carisma Therapeutics (NASDAQ: CARM - Get Free Report) and Protalex (OTCMKTS:PRTX - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based
Carmila: 2025 Annual Results
11:40am, Wednesday, 18'th Feb 2026
PARIS--(BUSINESS WIRE)--Regulatory News: Carmila (Paris:CARM): Three growth engines: NRI up 8.8% to €403.1 million Organic growth: adding 3.5% to net rental income, outpacing indexation by 110 basis
Financial Comparison: Context Therapeutics (NASDAQ:CNTX) vs. Carisma Therapeutics (NASDAQ:CARM)
01:34am, Thursday, 05'th Feb 2026
Context Therapeutics (NASDAQ: CNTX - Get Free Report) and Carisma Therapeutics (NASDAQ: CARM - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast
Carisma Announces Delisting from Nasdaq and SEC Deregistration
11:16am, Friday, 05'th Dec 2025
PHILADELPHIA , Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to p
Head-To-Head Survey: Achieve Life Sciences (NASDAQ:ACHV) vs. Carisma Therapeutics (NASDAQ:CARM)
02:24am, Sunday, 23'rd Nov 2025
Carisma Therapeutics (NASDAQ: CARM - Get Free Report) and Achieve Life Sciences (NASDAQ: ACHV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare th
Carmanah Minerals Engages Warrior Drilling for Heritage Project; Targets Historic Eagle Zone on Burin Trend, NL
10:07am, Thursday, 06'th Nov 2025
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Carmanah Minerals Corp. (CSE: CARM) ("Carmanah" or the "Company") is pleased to
Comparing Cassava Sciences (NASDAQ:SAVA) and Carisma Therapeutics (NASDAQ:CARM)
02:46am, Wednesday, 05'th Nov 2025
Carisma Therapeutics (NASDAQ: CARM - Get Free Report) and Cassava Sciences (NASDAQ: SAVA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare
Carmila - First-half 2025 Results: Acceleration in Growth and Recurring Earnings Outlook Revised Upwards
11:40am, Wednesday, 23'rd Jul 2025
PARIS--(BUSINESS WIRE)--Regulatory News: Marie Cheval, Chair and Chief Executive Officer of Carmila (Paris:CARM), commented: “Carmila's accelerated growth in the first half of 2025 reflects the scal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, CARM, ENZB on Behalf of Shareholders
09:48am, Saturday, 05'th Jul 2025
NEW YORK, July 05, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders
07:57pm, Friday, 27'th Jun 2025
NEW YORK , June 27, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE and CARM on Behalf of Shareholders
12:47pm, Monday, 23'rd Jun 2025
NEW YORK , June 23, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
CARM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Carisma Therapeutics Inc. Is Fair to Shareholders
09:49am, Monday, 23'rd Jun 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Carisma Therapeutics Inc. (NASDAQ: CARM) and OrthoCellix, Inc. is fair to Carisma share
PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly-owned subsidiary of Ocugen, Inc. (Nasd
Carisma Therapeutics Provides Corporate Updates
04:30pm, Monday, 31'st Mar 2025
Company to explore strategic alternatives to advance liver fibrosis and oncology assets and reduce operational cash burn PHILADELPHIA , March 31, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq
Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
07:30am, Wednesday, 19'th Feb 2025
PHILADELPHIA , Feb. 19, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Michael Klichinsk
